All data are based on the daily closing price as of September 6, 2024
c
Center Laboratories
4123.TWO
1.36 USD
-0.01
-0.73%
Overview
Last close
1.36 usd
Market cap
972.28M usd
52 week high
1.81 usd
52 week low
1.25 usd
Target price
N/A usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
20.3503
Price/Book Value
1.6523
Enterprise Value
1.04B usd
EV/Revenue
21.9429
EV/EBITDA
-13.4142
Key financials
Revenue TTM
47.57M usd
Gross Profit TTM
8.11M usd
EBITDA TTM
9.78M usd
Earnings per Share
-0.08 usd
Dividend
0.05 usd
Total assets
27.05B usd
Net debt
4.32B usd
About
Center Laboratories, Inc., a pharmaceutical company, engages in the manufacturing and trading of pharmaceuticals in Taiwan and internationally. It engages in the research and development of small molecule drugs, as well as solutions for neurological and oncological diseases; development of proteins and antibodies; and pharmaceutical CDMO, medical device, software as medical device, nutritional health and agribiotechnology, stem cell and immune cell therapy, and industry investment and venture capital businesses. The company also supplies glass fibre pressure vessels. Center Laboratories, Inc. was founded in 1959 and is headquartered in Taipei City, Taiwan.